This nation-wide availability builds on Cardax’s previously announced national purchase order and mutual exclusivity agreement with GNC.
GNC is the Exclusive “Brick-and-Mortar” Retailer of ZanthoSyn® in the United States |
[07-December-2017] |
HONOLULU, Dec. 7, 2017 /PRNewswire/ -- Cardax (OTCQB: CDXI) announced today that ZanthoSyn®, the Company’s premium astaxanthin dietary supplement for inflammatory health and longevity, is now available at more than 3,000 corporate stores across the U.S. owned and operated by GNC Holdings, Inc. (“GNC”). This nation-wide availability builds on Cardax’s previously announced national purchase order and mutual exclusivity agreement with GNC. With approximately 9,000 retail locations worldwide, GNC is the leading specialty retailer of health, wellness, and performance products. GNC sales associates at its more than 3,000 corporate stores can also assist customers by arranging for free home delivery of ZanthoSyn® via the “GNC Delivers” service. GNC’s more than 1,100 franchise stores also have the option to stock ZanthoSyn®. “GNC is an ideal retail channel for us,” said David G. Watumull, Cardax CEO. “Moving from our first conversation to becoming the top selling product in Hawaii GNC stores and forging an exclusive brick-and-mortar national distribution agreement in less than a year speaks to our strong working relationship and the growing profile of the ZanthoSyn® brand. This progress is also powered by a very enthusiastic response from consumers to ZanthoSyn® as a premium astaxanthin dietary supplement for inflammatory health and longevity.” Cardax plans to drive ZanthoSyn® sales nationally through its two-pronged approach, modeled after Cardax’s successful program in Hawaii:
The Company’s relationship with GNC reflects Cardax’s mission to develop and commercialize the safest, most effective anti-inflammatory products for health and longevity. Cardax is also developing and commercializing CDX-085, its next generation patented ZanthoSyn® product for highly concentrated astaxanthin product applications. “Moving from Hawaii to all U.S. corporate GNC stores is a major achievement that underscores our vision and strategy to become the inflammatory health, anti-aging leader,” added George W. Bickerstaff, Cardax Chairman. About Cardax About ZanthoSyn® About Astaxanthin Media and Investors Safe Harbor * These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. -------------------------------------
View original content with multimedia:http://www.prnewswire.com/news-releases/zanthosyn-from-cardax-now-available-at-3000-gnc-corporate-stores-in-the-us-300568241.html SOURCE Cardax, Inc. | ||
Company Codes: OTC-BB:CDXI, OTC-PINK:CDXI, OTC-QB:CDXI |